Hemoadsorption Contribution in Failing Fontan Pediatric Heart Transplantation

Carlo Pace Napoleone1, Enrico Aidala1, Maria Teresa Cascarano1

  • 1Pediatric and Congenital Cardiac Surgery, Regina Margherita Children's Hospital, Torino, Italy.

Cardiorenal Medicine
|January 14, 2024
PubMed

Insights

This study shows that using a hemoadsorption filter during pediatric heart transplantation significantly reduced inflammatory markers. This approach improved outcomes in a high-risk patient, suggesting a potential benefit for complex pediatric transplant cases.

Area of Science:

  • Cardiovascular Surgery
  • Pediatric Cardiology
  • Biomedical Engineering

Background:

  • Pediatric cardiothoracic surgery with cardiopulmonary bypass (CPB) can trigger a systemic inflammatory response, particularly in high-risk patients.
  • This inflammatory response can negatively impact surgical outcomes.
  • Adsorptive blood purification is explored as a method to mitigate this response.

Observation:

  • A 10-year-old pediatric heart transplant recipient with a failing Fontan circulation and compromised condition was treated.
  • The Jafron HA 380 hemoadsorption filter was integrated throughout the cardiopulmonary bypass (CPB) period.
  • Interleukin-6 (IL-6), an inflammatory biomarker, was monitored.

Findings:

  • The patient experienced an uneventful postoperative recovery, comparable to elective pediatric heart transplants.
  • IL-6 levels demonstrated a significant reduction post-surgery.
  • Postoperative IL-6 levels normalized within two days, aligning with typical uneventful transplant courses.

Implications:

  • Hemoadsorption filtration may enhance outcomes in pediatric heart transplantation.
  • This technique shows promise for improving results in very high-risk pediatric transplant recipients.
  • Further research into adsorptive techniques in pediatric cardiac surgery is warranted.
Abstract

Related Concept Videos